chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Around 8:30 pm on 7/26 my heart began racing and my chest felt tight. I then started getting a fever which was 101 so I took two Advil. About an hour passes by and I recheck my temperature and it?s 103. So I take two Tylenol. By 11:30 that night my temperature reaches 104.7. I take a like warm bath to try and get my temperature down and I start throwing up. I go and lay in bed trying not to move because I was so sick. I wake up around 2 am take more Tylenol because my temp was over 103. The next morning I continue to have a fever but stays between 101-103 with both alternating Advil and Tylenol. My fever finally lowers to 100-101 mid afternoon. I call my doctors office and let them know my symptoms to which they say are normal.  7/28 fever breaks mid afternoon. I am very weak and fatigued.  Chest still feels tight.  7/29 still very weak fatigued and light headed when standing.
Sore muscles on arm injected, moderate joint pain all over. Breast pain and tenderness. Severe bloating. Onset of heavy menstral period with blood clots. Tiredness, weakness, dizziness, some nausea.
Aches Chills Fever  From 9pm, Friday, April 23rd until 9pm Sunday, April 25th --- Weakness followed
This spontaneous report as received from a registered nurse refers to a unknown number of patients of unknown age. Medical history and drug reactions/allergies were not reported. On an unknown date, the patients were vaccinated with MMR II (lot, dose, and route not reported). Concomitant medication was not reported. ON 06-JAN-2014, improperly stored MME II may have been administered (unknown number of doses, demographics unspecified). No adverse event reported. Additional information is not expected.
Case number PHEH2014US024271, is an initial spontaneous report received from a nurse on 02 Dec 2014, with a follow up received from nurse on 21 Jan 2015. This report refers to a 58 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 14511P, expiry date: Mar 2015) intramuscularly into the left deltoid at a dose of 0.5 ml on 18 Nov 214. Nurse reported that PFS of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. The patient did not experience any adverse reaction due to the maladministration. No further information was provided. Follow up received from nurse on 21 Jan 2015: updated site of vaccination and reporter comment.
Shot was around 2:30p on Thursday 2/11 woke up with fever, nausea and an itchy thigh/side on 2/12 noticed a rash around noon on 2/12 which looked pimply. rash progressed to be extremely itchy looked like hives and kept spreading by 2/15 rash was sensitive and hurt to touch even when pulling clothes up and down. Now 2/16 it hurts/shoot pain. Rash is along a dermatome- Had telehealth visit with Dr and he dx Shingles with the likelihood that this was activated by the vaccination
Patient reports that about 25 minutes after receiving the vaccine she began to feel like her throat was swollen and the her voice was changed and she had a feeling of pressure on her vocal chords.  She also noted that she seemed to have an increase in heart rate. She took a dose of Benadryl and no further symptoms were experienced.  She reports that these symptoms resolved by next day but she felt extreme fatigue for the next few days.
Patient received Janssen COVID-19 vaccination 3/18/21 from an offsite vaccination clinic. Next, patient scheduled an appointment for a Moderna series for 6/24/21. Walgreens was not aware that he had received Janssen vaccination and proceeded with the first dose of a Moderna series on 6/24/21. On 7/23/21 patient returned to Walgreens for the second Moderna vaccination and this is when it was discovered that he already had received Janssen. No additional doses of vaccination were administered, the patient was notified that there is not enough evidence to support multiple COVID-19 vaccines, and his doctor was notified.
Sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Sore arm). The outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 12-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he/she received shingles vaccine but the vaccine was administered slowly and his/her was not that bad  The patient experienced very sore arm for a few days. Follow-up would not possible as no contact details were available.
On 07/04/2022 someone who I had recently traveled with informed me that they were positive for COVID-19. I then tested for COVID-19 with an at home test and was positive. I had difficulty swallowing, a sore throat, and a strange feeling in my chest but was not coughing much but a few days later I began to develop a cough that was producing phlegm. After testing positive I called my doctor who prescribed PAXLOVID. My symptoms were progressively worse each day. I was very fatigued and had to nap a lot and my voice was extremely horse to the point that I would lose my voice after speaking for as little as 20 minutes. I had to order food in for at least a week because I could not cook. I had a temperature of 103. My doctor advised that I use TYLENOL to treat my fever, but I couldn't swallow the pills. I couldn't sleep through the night due to the inability to swallow. After taking the PAXLOVID I began to feel better but it took at least 2 weeks before I was able to cook again.
Patient fainted at home. She complained of very painful injection site in her left arm, legs numb and tingly, chills, nausea, dizziness and temp of 100.3.  She was taken to the emergency room for evaluation and treatment. She  had blood work, EKG, and CTA done. All results normal. Patient was then discharged home. Patient called the office back on 7/2 and stated her symptoms seemed to have resolved then returned. She was complaining of dizziness, muscle aches, and muscle aches.
Headaches; his eye was hurting when he looks up; Chills; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 15 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Aug2021 (Lot number: FA7485, Expiration Date: Oct2021) at the age of 15 years as dose 2, 0.3 ml single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Vaccine Name: First dose of the COVID vaccine, Lot Number / Expiry Date: FA7484/ Sep2021, Route, Anatomical Location:  Left arm, No. of Previous Doses: This was dose 1 of 2. , Date: 26Jul2021), administration date: 26Jul2021, when the patient was 15 years old, for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headaches"; EYE PAIN (non-serious), outcome "unknown", described as "his eye was hurting when he looks up"; CHILLS (non-serious), outcome "unknown", described as "Chills".  Follow-up attempts are completed. No further information is expected.
Patient received expired Moderna Covid-19 vaccine; Immunocompromised patient did not received 3 full primary series doses; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Immunocompromised patient did not received 3 full primary series doses) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (Primary dose.). Past adverse reactions to the above products included No adverse reaction with Pfizer. Concurrent medical conditions included Immunocompromised.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Immunocompromised patient did not received 3 full primary series doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna Covid-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Immunocompromised patient did not received 3 full primary series doses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The patient received their first dose of the Moderna vaccine on 30-Apr-2021 and received the Primary dose as a Pfizer vaccine. No other information was known about these doses or adverse reactions.  The patient received expired Moderna Covid-19 vaccine as their first booster dose on 18-Apr-2022. Reportedly, no other adverse reactions or side effects reported on 18-Apr-2022.  It was also reported that the Immunocompromised patient did not receive 3 full primary series doses.  The patient's weight was unknown.  No treatment information was provided.   This case was linked to MOD-2022-544265 (Patient Link).
Raised red bumps in a rash all over the abdomen, arms & legs. First noticed at 6 pm, majority of rash gone the next morning except. Under arms and upper legs.
Extreme fatigue, initiation of previous arthritis pain; pain lasted a few days, fatigue lasted for a week.
Extremely cold with chills; Body aches; Extremely cold with chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Extremely cold with chills), PAIN (Body aches) and CHILLS (Extremely cold with chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Feb-2021, the patient experienced FEELING COLD (Extremely cold with chills), PAIN (Body aches) and CHILLS (Extremely cold with chills). At the time of the report, FEELING COLD (Extremely cold with chills), PAIN (Body aches) and CHILLS (Extremely cold with chills) outcome was unknown.            Concomitant medications were not provided. Treatment details were not provided.
Information has been received from a medical assistant (MA), concerning a 67 year old female patient, with penicillin and caffeine hypersensitivity, who on 16-MAY-2007 was vaccinated with a dose, 0.5ml, IM, of Pneumovax 23 (Lot #655765/0061U). Concomitant therapy included simvastatin (MSD), NIASPAN, and vitamins (unspecified). On 17-MAY-2007 the patient experienced slight redness and tenderness on her left arm at the injection site, and had chills, a fever (not specified) and was achy. On 18-MAY-2007 the patient was seen in the office, and the NA reported the area was swollen and red. At the time of this report, the patient had not recovered from the events. Additional information has been requested.
This patient's mother noticed that the patient reported left arm still hurts, upon exam the left shoulder was red, warm, and swollen (02/10/00). The patient had not reported any problems prior to that. No fever.
REDNESS AND HIVES TO NECK AND TRUNK OF BODY. SX'S BEGAN TO DEVELOP AT APPROXIMATELY 12:30 PM. PT REPORTED TO CLINIC AT APPROXIMATELY 12:45 PM. PT RECEIVED EPINEPHRINE 0.3 MG IM X 1 AND BENADRYL 50MG PO X 1. NO ADVERSE RXN'S NOTED. PT TOLERATED WELL D/C'D HOME WITH NO LIMITATIONS.
1/6/23 I got sick with symptoms of sore throat, wheezing, coughing, phlegm, runny nose, headache and felt lousy while on a cruise. I took an At Home COVID Test on 1/11/23 and it was positive.  I called my doctor, and he thought I had bronchitis and sinusitis. He gave me prescriptions for that.  I went to the clinic to see the doctor on 1/13/23. Did not test me again and did not do anything for me.  I went with my husband to the doctor and while there, he gave me medication for my sinusitis and bronchitis. On 1/16/23 I tested positive for COVID with an at home COVID test.  After all the medication was taken, I was not better. I went back to the doctor because I was not feeling well, and he prescribed another round of medication and then I got better.  Two weeks ago I had a sore throat again and feeling lousy with aches and pains. I was coughing again. I went to the walk-in clinic, tested me for COVID, Flu and Flu B was positive and I was diagnosed with bronchitis. He prescribed medication. Nine days later, I am still stick with night sweats. I had a telehealth and was put on steroids, Z-Pak, cough syrup with codeine which I will take for the next 12 days.
Intense headache by 430pm Arm soreness by 3pm Intense Chills and body aches by 2am
pt recvd vax 11JAN93 & 13JAN93 exp serum-sickness-like synd w/nausea, body aches, fatigue; pt also devel a non-pruritic macular lacy rash on foreamrs which spread to upper arms, upper thighs, breasts, & abdo w/blanching observed;
skin rash/rash; swollen lymph nodes/swollen lymph nodes on my right neck; has a bruise on the back of her neck or like her muscle got hurt; has a bruise on the back of her neck or like her muscle got hurt; asthma/allergic asthma; ear hurts; Shingles; This is a spontaneous report from a contactable consumer(patient). A 56-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8730), dose 1 via an unspecified route of administration, administered in Arm Left on 22Mar2021 08:00 (at the age of 56-years-old) as dose 1, single for COVID-19 immunisation. The patient's medical history included Allergic asthma from an unknown and was ongoing. The patient concomitant medications were not reported. The patient with a history of allergic asthma who received the first dose of the COVID19 vaccine on (Monday) on 22Mar2021 at 8 AM. About 8 hours later around 3 PM (Monday) on 22Mar2021 she started to start felling some asthma /Asthmatic, like dealing with bad allergies because she has allergic asthma. It just got like she had dealing bad allergies. Not bad, but similar to when she is exposed to a lot of dust. She took her spray as she periodically took it. On (Wednesday) on 24Mar2021 (36 hours after), she noticed a skin rash and swollen lymph nodes on the right side of her neck, which was the opposite side of where she got her shot, she got shot on the left side on her arm. It feels like she has a bruise on the back of her neck or like her muscle got hurt. Sometimes her ear hurts too. She got the vaccination on her left side. She doesn't know if this was fairly typical or not. She was uncertain if she should get the second dose because she heard second shot is worse. The patient received the treatment spray for asthma. She has rash and swollen lymph still and she was wondering is it safe for me to take second dose giving that she has have this symptom. She saw Doctor on Friday (26Mar2021) and she told her that she got shingles, the rash, it turned out to be Shingles. She asked has a lot of people reported shingles. Her second dose scheduled for 12Apr2021. The outcome of skin rash/rash and swollen lymph nodes/swollen lymph nodes on my right neck was not resolved. The outcome of asthma/allergic asthma has a bruise on the back of her neck or like her muscle got hurt, ear hurts, shingles was unknown.  No follow-up attempts are possible. No further information is expected.
Moderna COVID-19 Vaccine EUA dose given 1 days after BUD for refrigeration
Itchiness on her arm; Major rash; Redness; Swelling; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Oct-2021 and was forwarded to Moderna on 25-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness on her arm), VACCINATION SITE RASH (Major rash), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness on her arm), VACCINATION SITE RASH (Major rash), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling). At the time of the report, VACCINATION SITE PRURITUS (Itchiness on her arm), VACCINATION SITE RASH (Major rash), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were reported.   This case was linked to MOD-2021-362118 (Patient Link).
onset of temp 101.0 & rash 25MAR98 w/resolution of both on 29MAR98
Initial unsolicited report received from a Physician via partner company Pfizer (manufacturer reference Number: 2017107597) on 22-MAR-2017. This case involves a female patient (onset age was unknown) who was vaccinated with dose of TETANUS TOXOID (batch number, expiry date, dose and dose in series were not reported) in an unknown site on an unknown date. Patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patient had developed allergy to Tetanus Vaccine and Toxoids. Laboratory investigations and corrective treatment were not reported. The outcome of events was not reported. List of documents held by sender: none.
No adverse event noted, however when patient arrived for their 2nd dose, we realized she was under 18.
1st dose in 2019, 2nd dose 09MAY2022; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 16th October 2019).   On 9th May 2022, the patient received the 2nd dose of Shingrix (intramuscular). On 9th May 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 11-MAY-2022 Reporters comment: The patient self-reported the case.  The patient received first dose of Shingrix dose on 16th October 2019 and second dose on 09th May 2022 in an unknown arm. She had nothing else to report. Additional supportive information: The patient received 2nd dose of Shingrix, later than the recommended schedule, which led to lengthening of vaccination schedule.
On 10/21/99, the pt experienced arm swelling to 3 times the normal size at the injection site. The site was painful. The arm was 2 times the normal size at the time of the report.
Shoulder tenderness; Got a rash on the chest; Nausea; Chills; Headache; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Shoulder tenderness), RASH (Got a rash on the chest), NAUSEA (Nausea), CHILLS (Chills) and HEADACHE (Headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Shoulder tenderness), RASH (Got a rash on the chest), NAUSEA (Nausea), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, VACCINATION SITE PAIN (Shoulder tenderness), RASH (Got a rash on the chest), NAUSEA (Nausea), CHILLS (Chills) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment included ibuprofen.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. Information regarding the patients current condition and medical history was not provided. On an unknown date in March 2016 an unspecified number of patients were vaccinated with improperly stored (temperature excursion-55F) dose of ROTATEQ lot # L027076, expiry date-25-MAY-2017, oral. No adverse effects were reported. No laboratory tests were reported. No product quality complaint (PQC) was involved. No further information was provided. Additional information is not expected as the reporter did not wish any further contact.
I have just been diagnosed with choroidal Melanoma in my left eye.  I will be undergoing Radiation plaque on March 13 i could find no database to report new diagnosis of cancer or other rare disease following the covid vaccines and I am sure you want to keep up with these statistics
1) high fever -> 24 hours (reduced via TYLENOL + bath) 2) shivering 3) unusual behavior -> 48+ hours 4) fast heart beat -> 12+ hours 5) intense sweating -> 12+ hours 6) vomited (1x) 7) low food intake -> no appetite (48+ hours) 8) irritable -> 48+ hours 9) sleeplessness -> 48+ hours 10) temper tantrums -> unusual to my son 48+ hours 11) very fussy -> 48+ hours 12) developed chest cold 6/7-6/9/08.
CHILD 8 Y.O. with MINOR consent for first dose Pfizer, received adult Lot#.
Woke up this AM with headache and neck pain radiating down to thoracic spine. Approximately 1/2 hr pt fell and due to dizziness/passed out and hit (Lt) side of head above eye. Pt states she doesn't "feel right".
Patient had no adverse reaction to the first Shingrix vaccine which was 1 year ago.  Her arm was very sore on Day 1 after the vaccine but no other symptoms.  On day 2 she noticed that it itched about 1 inch below and to the left of where the vaccine was given.  When she stopped by to see us today on day 3 the area was red and warm and was approximately 2 inches wide by 3 inches long.  It was itching and burning.  Advised her to use ice/cool pack on it and possibly try some topical hydrocortisone.  Will call her to follow up again in 2 days.  Explained that although this is not terribly common it is in the package literature.
Chills, tiredness and migraine.  Lasted all day on 12/11.  The chills/tiredness got worse as the day progressed.  Took migraine rescue meds and that helped but the migraine did not completely dissipate until the am of 12/12.
Child's right arm was swollen and red and hot to touch. Gave child Benadryl and applied ice packs to arm. Patient was a no show for follow up appt.
3 days fever to T max 101 (12/31/20-1/2/21). Full body red blotchy rash (starting 1/4/2021)